Luminex Corporation is a medical instruments & supplies business based in the US. Luminex Corporation shares (LMNX) are listed on the NASDAQ and all prices are listed in US Dollars. Luminex Corporation employs 1,325 staff and has a trailing 12-month revenue of around $437.7 million.
Our top picks for where to buy Luminex Corporation stock
How to buy Luminex Corporation stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LMNX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Luminex Corporation stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Luminex Corporation stock price (NASDAQ: LMNX)
Use our graph to track the performance of LMNX stocks over time.Luminex Corporation shares at a glance
Latest market close | $36.89 |
---|---|
52-week range | $0.00 - $0.00 |
50-day moving average | $36.84 |
200-day moving average | $33.44 |
Wall St. target price | $37.00 |
PE ratio | 73.8323 |
Dividend yield | $0.38 (1.03%) |
Earnings per share (TTM) | $0.50 |
Is it a good time to buy Luminex Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Luminex Corporation price performance over time
Historical closes compared with the close of $36.89 from 2021-05-28
1 week (2024-08-27) | N/A |
---|---|
1 month (2024-08-03) | N/A |
3 months (2024-06-03) | N/A |
6 months (2024-03-03) | N/A |
1 year (2023-09-03) | N/A |
---|---|
2 years (2022-09-03) | N/A |
3 years (2021-09-03) | N/A |
5 years (2019-09-06) | 90.03% |
Is Luminex Corporation stock undervalued or overvalued?
Valuing Luminex Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Luminex Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Luminex Corporation's P/E ratio
Luminex Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 74x. In other words, Luminex Corporation shares trade at around 74x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Luminex Corporation's PEG ratio
Luminex Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Luminex Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Luminex Corporation's EBITDA
Luminex Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $85.6 million.
The EBITDA is a measure of a Luminex Corporation's overall financial performance and is widely used to measure a its profitability.
Luminex Corporation financials
Revenue TTM | $437.7 million |
---|---|
Operating margin TTM | 12.49% |
Gross profit TTM | $247.9 million |
Return on assets TTM | 5.06% |
Return on equity TTM | 4.97% |
Profit margin | 5.39% |
Book value | $10.55 |
Market Capitalization | $1.8 billion |
TTM: trailing 12 months
Luminex Corporation share dividends
Dividend payout ratio: 1.63% of net profits
Recently Luminex Corporation has paid out, on average, around 1.63% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.08% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Luminex Corporation shareholders could enjoy a 1.08% return on their shares, in the form of dividend payments. In Luminex Corporation's case, that would currently equate to about $0.38 per share.
While Luminex Corporation's payout ratio might seem low, this can signify that Luminex Corporation is investing more in its future growth.
Luminex Corporation's most recent dividend payout was on 7 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 15 June 2021 (the "ex-dividend date").
Luminex Corporation share price volatility
Over the last 12 months, Luminex Corporation's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Luminex Corporation's is 0.5734. This would suggest that Luminex Corporation's shares are less volatile than average (for this exchange).
Luminex Corporation overview
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas. .
Frequently asked questions
What percentage of Luminex Corporation is owned by insiders or institutions?Currently 4.354% of Luminex Corporation shares are held by insiders and 92.552% by institutions. How many people work for Luminex Corporation?
Latest data suggests 1,325 work at Luminex Corporation. When does the fiscal year end for Luminex Corporation?
Luminex Corporation's fiscal year ends in December. Where is Luminex Corporation based?
Luminex Corporation's address is: 12212 Technology Boulevard, Austin, TX, United States, 78727 What is Luminex Corporation's ISIN number?
Luminex Corporation's international securities identification number is: US55027E1029 What is Luminex Corporation's CUSIP number?
Luminex Corporation's Committee on Uniform Securities Identification Procedures number is: 55027E102
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
7 best day trading platforms of 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Trading for beginners: 11 best trading platforms to get started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 best international stock brokers to invest in foreign assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 best discount brokers of 2024 for low-cost trading and investing
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
10 best stock apps of 2024 to elevate your mobile trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
5 top graphene stocks to invest in today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question